Literature DB >> 32467584

A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease.

Richard K Burt1, Robert Craig2, Laura Yun2, Amy Halverson3, Kathleen Quigley4, Indira Arnautovic4, Xiaoqiang Han4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32467584     DOI： 10.1038/s41409-020-0953-y

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

Review 1.  Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Authors:  Tobias Alexander; Raffaella Greco
Journal:  Bone Marrow Transplant       Date:  2022-05-16       Impact factor: 5.174

2.  Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis.

Authors:  Kaja Kasarełło; Emilian Snarski; Dorota Sulejczak; Tomasz Ciesielski; Agnieszka Wiśniewska; Robert Wrzesień; Agnieszka Cudnoch-Jędrzejewska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-06-28       Impact factor: 4.291

Review 3.  Medical, ethical, and legal aspects of hematopoietic stem cell transplantation for Crohn's disease in Brazil.

Authors:  Milton Artur Ruiz; Roberto Luiz Kaiser Junior; Lilian Piron-Ruiz; Priscila Samara Saran; Lilian Castiglioni; Luiz Gustavo de Quadros; Tainara Souza Pinho; Richard K Burt
Journal:  World J Stem Cells       Date:  2020-10-26       Impact factor: 5.326
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.